What is Tissue Analytics?
Tissue Analytics, Inc. is a Baltimore-based health-tech innovator specializing in artificial intelligence-powered software designed to optimize wound management and clinical documentation. By leveraging advanced machine learning and computer vision, the platform enhances the precision of electronic medical records (EMR) data, providing critical insights for clinicians, researchers, and industry stakeholders. The company distinguishes itself through seamless interoperability, utilizing SMART on FHIR standards to integrate directly with industry-leading platforms such as Epic, Cerner, and Allscripts. This strategic positioning allows the firm to address systemic inefficiencies in healthcare workflows, effectively bridging the gap between complex clinical data and actionable patient outcomes.
How much funding has Tissue Analytics raised?
Tissue Analytics has raised a total of $7.7M across 3 funding rounds:
Angel/Seed
$750K
Debt
$1.9M
Series A
$5M
Angel/Seed (2015): $750K with participation from DreamIt Health and Tencent
Debt (2016): $1.9M, investors not publicly disclosed
Series A (2018): $5M supported by Intermountain Health, Dreamit Ventures, Molnlycke Health Care, Penn Medicine, DigiTx Partners, and Tencent
Key Investors in Tissue Analytics
Tencent
Tencent is a global technology conglomerate that invests in high-growth innovation, providing capital and ecosystem support to companies developing advanced digital platforms and artificial intelligence solutions.
Intermountain Health
Intermountain Health is a prominent nonprofit integrated health system that focuses on improving patient outcomes through coordinated care and the adoption of cutting-edge medical technologies.
Dreamit Health
Dreamit is a top-tier global accelerator and venture capital firm that specializes in driving business velocity and market traction for breakthrough technology startups in the healthcare vertical.
What's next for Tissue Analytics?
With the infusion of its most recent capital, Tissue Analytics is well-positioned to accelerate its market penetration and deepen its technological moat. The company's focus remains on expanding its footprint within large-scale health systems, where its automated documentation tools provide measurable improvements in data quality and operational efficiency. As the digital health sector continues to prioritize data-driven therapeutics and personalized medicine, Tissue Analytics is poised to leverage its existing integrations to become an indispensable component of the modern clinical infrastructure. Future growth will likely center on scaling its computer vision capabilities to address broader therapy areas, further cementing its role as a vital partner for healthcare providers seeking to modernize their digital ecosystems.
See full Tissue Analytics company page
